Severe coagulopathy Specific genetic Specific genetic lesion lesion Response to differentiating agents (RA, ATO) agents (RA, ATO) Striking sensitivity.
Childhood Acute Lymphoblastic Leukemia: Risk Stratification in Developing Countries Shripad Banavali MD(Med;Bom), BC(Ped;USA), BE(Hem-Onc;USA) Tata Memorial.
Long term survival outcomes of Acute Promyelocytic Leukemia.
Caesarea, April 2008 D.Hoelzer J.W.Goethe University Frankfurt for the GMALL Study Group German Multicenter Studies for Adult Acute Lymphoblastic Leukemia.
Dr. Gopichand Pendurti M.B.B.S ACTIVITY OF RITUXIMAB AND OFATUMUMAB AGAINST MANTLE CELL LYMPHOMA(MCL) IN VITRO IN MCL CELL LINES BY COMPLEMENT DEPENDENT.
Current use of imatinib in the treatment of chronic myeloid leukaemia Michael O’Dwyer Haematologica March 2003.
Author Disclosure Information
Idiotype vaccine therapy (BiovaxID) in follicular lymphoma in first complete remission BV301 Phase III clinical trial results Schuster SJ*, Neelapu SS*,
NEJM RA-pathogenesis
Acute myeloid leukaemia. Treatment with curative intent is undertaken in the majority of adults below the age of 60 years, provided there is no significant.
